http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012176958-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed81c6ea93edb0d59f9c35d7a9c6cd52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 |
| filingDate | 2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85e0934108bc599549c5bc505d474c47 |
| publicationDate | 2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012176958-A |
| titleOfInvention | Treatment of smooth muscle hyperfunction with (R) -oxybutynin and (R) -desethyloxybutynin |
| abstract | A method for minimizing side effects associated with administration of racemic oxybutynin or racemic desethyloxybutynin. To treat cholinergic mediated hypersmooth muscle function, urinary bladder smooth muscle function, such as urinary incontinence, using optically pure R (-)-isomers of oxybutynin and desethyl-oxybutynin And alleviate symptoms associated with gastrointestinal smooth muscle hyperactivity, such as irritable bowel syndrome. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021516218-A |
| priorityDate | 2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.